AstraZeneca India Appoints New Directors, Promotes One
AstraZeneca Pharma India Ltd has announced significant appointments and a promotion within its Senior Management Personnel (SMP). Mr. Mihir Parikh has been appointed as Director - Commercial Excellence, BD & Strategy, effective August 1, 2026. Mr. Amay Ashok Pandey will join as Director – Oncology Business Unit, effective September 1, 2026. Additionally, Mr. Vinay Sharma has been promoted to Director - Rare Diseases Business Unit from his previous role as Business Unit Head - Rare Disease Business Unit, also effective August 1, 2026. These appointments and promotions are based on the recommendation of the Nomination and Remuneration Committee and approved by the Board of Directors, aligning with SEBI Listing Regulations.
Key Highlights
- Three senior management changes announced by AstraZeneca India.
- New Directors appointed in Commercial Excellence and Oncology.
- One Director promoted in Rare Diseases Business Unit.
- All changes are effective from August or September 2026.
- Appointments align with SEBI Listing Obligations and Disclosure Requirements.
Price Impact
More from ASTRAZEN